ArriVent BioPharma Inc. C... (AVBP)
18.54
-0.03 (-0.16%)
At close: Mar 28, 2025, 1:58 PM
ArriVent BioPharma Common Stock Revenue
ArriVent BioPharma Common Stock reported an annual revenue of $0, reflecting a 0% growth. For the quarter ending September 30, 2024, ArriVent BioPharma Common Stock generated $0 in revenue.
Revenue (ttm)
$0
Revenue Growth
0%
Price / Sales Ratio
0
Revenue / Employee
$0
Employees
40
Market Cap
630.66M
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | % Change |
|---|---|---|
| Dec 31, 2023 | 0 | n/a |
| Dec 31, 2022 | 0 | n/a |
| Dec 31, 2021 | 0 | n/a |